Hypoparathyroidism - management, information needs, and impact on daily living from the patients' perspective: results from a population-based survey

Hormones (Athens). 2023 Sep;22(3):467-476. doi: 10.1007/s42000-023-00459-1. Epub 2023 Jun 28.

Abstract

Purpose: Hypoparathyriodism (hypoPT) is a rare endocrine disorder. It is not known how hypoPT is managed in Germany or whether patients have unmet information needs or impairments in their daily living.

Methods: HypoPT patients at a minimum of 6 months' post-diagnosis were invited to participate in an online survey through their treating physician or through patient organizations. An extensive questionnaire, which was developed and pilot-tested with hypoPT patients, was administered.

Results: A total of 264 patients with a mean age of 54.5 years (SD: 13.3), 85.2% female and 92% with postsurgical hypoPT, participated in the study. In total, 74% of the patients reported regular monitoring of serum calcium at least every 6 months, with lower control frequencies for phosphate (47%), magnesium (36%), creatinine (54%), and parathyroid hormone (50%), and 24-h urine calcium excretion (36%) on a yearly basis. Information on symptoms of hypo- and hypercalcemia was available in 72 and 45% of the patients. Information needs were related to the disease and its treatment as well as to nutrition, physical activities/sports, and support opportunities. Statistically significant differences for all information needs in association with symptom burden were observed. Hospitalization for hypocalcemia was reported by 32%, nutritional impairments (38%) or impact on work ability (52%) was available among patients with hypoPT.

Conclusion: HypoPT patients experience impairments in daily living and report unmet information needs. Patient and physician education regarding hypoPT is one of the key concepts for improving the management of patients with hypoPT.

Keywords: Hypoparathyroidism; Impairment; Information; Management; Patient perspective.

MeSH terms

  • Calcium*
  • Female
  • Humans
  • Hypoparathyroidism* / epidemiology
  • Hypoparathyroidism* / therapy
  • Information Management
  • Male
  • Middle Aged
  • Parathyroid Hormone
  • Postoperative Complications

Substances

  • Calcium
  • Parathyroid Hormone